Akademisyen

ATİLA YILDIRIM

DOKTOR ÖĞRETİM ÜYESİ

KARADENİZ TEKNİK ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

Ana Dal Sağlık Bilimleri Temel Alanı
Yan Dal Tıbbi Onkoloji (İç Hastalıkları)

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

Makale 12
Proje 0
Kitap 0
Bildiri 0
Patent 0
Sanatsal 0

Scopus (SJR) Q1 2 Q2 5 Q3 7 Q4 3

WoS (JCR) Q1 2 Q2 2 Q3 7 Q4 7

TR Index 1 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0

Üst %10 makale 0

Ort. yüzdelik 54.4%

Üst %1 payı 0.0%

Üst %10 payı 0.0%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Makale listesi

2026 Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study Cancers DOI 10.3390/cancers18121979 YÖKSİS SJR Q1 JCR Q2 OpenAlex 62.6%
2025 Health-related quality of life and psychosocial outcomes in long-term survivors treated with immune checkpoint inhibitors: a nationwide multicenter study FRONTIERS IN IMMUNOLOGY DOI 10.3389/fimmu.2025.1693295 YÖKSİS SJR Q1 JCR Q1 OpenAlex 79.2%
2025 Real-world comparison of doxorubicin–ifosfamide versus gemcitabine–docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective study DISCOVER ONCOLOGY DOI 10.1007/s12672-025-03886-1 YÖKSİS SJR Q2 JCR Q3 OpenAlex 80.6%
2025 Altered Apoptosis in Endometriosis Compared with Ovarian Carcinoma Medicina DOI 10.3390/medicina61111983 YÖKSİS SJR Q2 JCR Q1 OpenAlex 29.4%
2024 Effect of Ki-67 proliferation index on survival in large cell neuroendocrine carcinoma of the lung Revista da Associação Médica Brasileira DOI 10.1590/1806-9282.20240398 YÖKSİS SJR Q3 JCR Q2 OpenAlex 67.9%
2024 The Effect of Chemotherapeutic Agents on Survival in Metastatic Non-Small-Cell Lung Cancer with KRAS Mutation INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY DOI 10.1055/s-0043-1775800 YÖKSİS SJR Q3 JCR Q4 OpenAlex 19.4%
2023 Anxiety Levels in Cancer Patients during the First Months of the COVID-19 Pandemic Sağlık Bilimlerinde Değer DOI 10.33631/sabd.1158643 YÖKSİS TR Index OpenAlex 63.7%
2023 Factors Affecting the Efficacy of Regorafenib in Metastatic Colorectal Cancer: Is Tumour Sidedness Important? JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN DOI 10.29271/jcpsp.2023.06.659 YÖKSİS SJR Q3 JCR Q3 OpenAlex 43.5%
2022 The relationship between albumin-bilirubin score and survival in patients operated for pancreatic cancer JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION DOI 10.47391/JPMA.2413 YÖKSİS SJR Q4 JCR Q4 OpenAlex 57.2%
2022 Hearing Loss After the First Low Dose Administration of Cisplatin Journal of the College of Physicians and Surgeons Pakistan DOI 10.29271/jcpsp.2022.09.1216 YÖKSİS SJR Q3 JCR Q4 OpenAlex 61.1%
2022 Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study European Journal of Clinical Pharmacology DOI 10.1007/s00228-022-03403-1 YÖKSİS SJR Q2 JCR Q3 OpenAlex 52.0%
2023 Factors Affecting the Efficacy of Regorafenib in Metastatic Colorectal Cancer: Is Tumour Sidedness Important? JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN DOI 10.29271/jcpsp.2023.06.659 YÖKSİS SJR Q3 JCR Q3 OpenAlex 43.5%
2023 Factors Affecting the Efficacy of Regorafenib in Metastatic Colorectal Cancer: Is Tumour Sidedness Important? College of Physicians and Surgeons Pakistan DOI 10.29271/jcpsp.2023.06.659 YÖKSİS SJR Q3 JCR Q3 OpenAlex 43.4%
2022 The relationship between albumin-bilirubin score and survival in patients operated for pancreatic cancer Pakistan Medical Association DOI 10.47391/JPMA.2413 YÖKSİS SJR Q4 JCR Q4 OpenAlex 57.2%
2022 The relationship between albumin-bilirubin score and survival in patients operated for pancreatic cancer Journal of the Pakistan Medical Association DOI 10.47391/JPMA.2413 YÖKSİS SJR Q4 JCR Q4 OpenAlex 57.2%
2022 Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study European Journal of Clinical Pharmacology DOI 10.1007/s00228-022-03403-1 YÖKSİS SJR Q2 JCR Q3 OpenAlex 52.0%
2022 Hearing Loss After the First Low Dose Administration of Cisplatin College of Physicians and Surgeons Pakistan DOI 10.29271/jcpsp.2022.09.1216 YÖKSİS SJR Q3 JCR Q4 OpenAlex 61.1%
2022 Evaluation of knowledge, attitudes and behaviors about COVID-19 among cancer patients ANNALS OF CLINICAL AND ANALYTICAL MEDICINE DOI 10.4328/ACAM.20940 YÖKSİS JCR Q4 OpenAlex 49.8%
2022 Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study. European journal of clinical pharmacology DOI 10.1007/s00228-022-03403-1 YÖKSİS SJR Q2 JCR Q3 OpenAlex 52.0%

Akademisyenlere dön